A Phase III Multicenter Clinical Trial of Analatro®[Antivenin Latrodectus (Black Widow) Equine Immune F9(ab)2] in Patients with Systemic Latrodectism

Trial ID:

14255

Trial Title:
A Phase III Multicenter Clinical Trial of Analatro®[Antivenin Latrodectus (Black Widow) Equine Immune F9(ab)2] in Patients with Systemic Latrodectism

Department Name:
Emergency Medicine

PI Name:
Holstege Christopher,

Advertisement:
Staff Flyers not intended for distribution to patients.

Division Name:
Emergency Medicine-Nontransport

Ages:
Adult
Child

Keywords:

Categories:

Volunteers:

Compensation:

Contact Person Name:
None None

Contact Person Email:

Contact Person Phone:

Sections

Personal tools

A Phase III Multicenter Clinical Trial of Analatro®[Antivenin Latrodectus (Black Widow) Equine Immune F9(ab)2] in Patients with Systemic Latrodectism

Other websites

Follow the Health System